Home  »  Finance   »  ImmunityBio Inc. (IBRX) – Don’t Believ...

ImmunityBio Inc. (IBRX) – Don’t Believe the Hype: Check The Facts

ImmunityBio Inc. (NASDAQ: IBRX) is -12.17% lower on its value in year-to-date trading and has touched a low of $2.60 and a high of $8.01 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $5.39 in the last trading session, with the day’s loss setting it -0.05% off its average median price target of $9.00 for the next 12 months. It is also 46.6% off the consensus price target high of $10.00 offered by 2 analysts, but current levels are 33.25% higher than the price target low of $8.00 for the same period.

Currently trading at $5.34, the stock is -1.05% and 0.52% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.12 million and changing -0.93% at the moment leaves the stock 10.35% off its SMA200. IBRX registered -14.29% loss for a year compared to 6-month gain of 52.57%.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored

The stock witnessed a -0.93% loss in the last 1 month and extending the period to 3 months gives it a 20.27%, and is -5.99% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.37% over the week and 9.00% over the month.

ImmunityBio Inc. (IBRX) has around 760 employees, a market worth around $2.27B and $0.60M in sales. Distance from 52-week low is 105.38% and -33.33% from its 52-week high. The company has generated returns on investments over the last 12 months (-90.10%).

ImmunityBio Inc. (IBRX) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for ImmunityBio Inc. (IBRX) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

ImmunityBio Inc. is expected to release its quarterly report on 02/28/2023.The EPS is expected to shrink by -51.40% this year

ImmunityBio Inc. (IBRX) Top Institutional Holders

The shares outstanding are 400.06M, and float is at 83.44M with Short Float at 28.45%.

ImmunityBio Inc. (IBRX) Insider Activity

A total of 0 insider transactions have happened at ImmunityBio Inc. (IBRX) in the last six months, with sales accounting for 0 and purchases happening 0 times.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell

 

 

100% Free. Stop Anytime. No Spam

111365

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.